NY-ESO-1 vaccine
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for NY-ESO-1 vaccine, covering 2016-10-04 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 [Phase 1]